Home/PaxMedica/Stephen D. Sheldon

SD

Stephen D. Sheldon

Chief Financial Officer

Therapeutic Areas

Neurology Psychiatry

PaxMedica Pipeline

Drug	Indication	Phase
PAX-101 (IV suramin)	Autism Spectrum Disorder (ASD)	Phase 3

Leadership Team at PaxMedica

Chairman and Chief Executive Officer

Chief Medical Officer

Executive Chairman of the Board (previously)

Former Chief Operating Officer

Charles J. Casamento

View full PaxMedica profile